{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:23:51Z","timestamp":1791062631030,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rdc.2015.04.009","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T17:37:07Z","timestamp":1432143427000},"page":"489-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis"],"prefix":"10.1016","volume":"41","author":[{"given":"Antonia","family":"Valenzuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Nandagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia D.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib1","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/acr.22121","article-title":"Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry","volume":"66","author":"Chung","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib3","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1 Suppl","key":"10.1016\/j.rdc.2015.04.009_bib4","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1 Suppl","key":"10.1016\/j.rdc.2015.04.009_bib5","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25 Suppl","key":"10.1016\/j.rdc.2015.04.009_bib6","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10S","key":"10.1016\/j.rdc.2015.04.009_bib7","first-page":"S245","article-title":"Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): comparison of outcomes in subtypes of pulmonary hypertension","volume":"62","author":"Domsic","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib8","first-page":"2347","article-title":"Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension","volume":"33","author":"Johnson","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000314587","article-title":"Pulmonary capillary hemangiomatosis associated with CREST syndrome: a case report and review of the literature","volume":"80","author":"McGuire","year":"2010","journal-title":"Respiration"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.009_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine"},{"issue":"1 Pt 2","key":"10.1016\/j.rdc.2015.04.009_bib12","first-page":"e65","article-title":"Pulmonary veno-occlusive disease: the bete noire of pulmonary hypertension in connective tissue diseases?","volume":"40","author":"O'Callaghan","year":"2011","journal-title":"Presse Med"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib13","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib16","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib17","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1378\/chest.124.6.2098","article-title":"Age and risk of pulmonary arterial hypertension in scleroderma","volume":"124","author":"Schachna","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rdc.2015.04.009_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.2002.tb04221.x","article-title":"Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis","volume":"966","author":"Scorza","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/03009740600844498","article-title":"Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"35","author":"Beretta","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1445-5994.2004.00646.x","article-title":"Isolated pulmonary hypertension in scleroderma","volume":"35","author":"Cox","year":"2005","journal-title":"Intern Med J"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3899\/jrheum.090697","article-title":"Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension","volume":"37","author":"Shah","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.009_bib24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/03009740801978871","article-title":"The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis","volume":"37","author":"Kampolis","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.009_bib25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib26","first-page":"2230","article-title":"Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody","volume":"34","author":"Steen","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib27","first-page":"199","article-title":"Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury","volume":"23","author":"Assous","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","article-title":"Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement","volume":"48","author":"Steen","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s11926-012-0302-2","article-title":"Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis","volume":"15","author":"Yaqub","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1183\/09031936.00181410","article-title":"Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma","volume":"39","author":"Dib","year":"2012","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib31","first-page":"462","article-title":"Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension","volume":"25","author":"Negi","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.009_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.009_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/art.1780350709","article-title":"Isolated diffusing capacity reduction in systemic sclerosis","volume":"35","author":"Steen","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.07-2324","article-title":"Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis","volume":"134","author":"Steen","year":"2008","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.009_bib36","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/annrheumdis-2012-201861","article-title":"Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients","volume":"72","author":"Shah","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.009_bib37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.009_bib38","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/annrheumdis-2011-200546","article-title":"Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry","volume":"71","author":"Bae","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib39","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Galie","year":"2009","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib40","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMcpc1305992","article-title":"Case 9-2014: a 34-year-old woman with increasing dyspnea (case records of the Massachusetts General Hospital)","volume":"370","author":"Saukkonen","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib42","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.009_bib43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib44","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/art.38172","article-title":"Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension","volume":"65","author":"Khanna","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.revmed.2004.01.019","article-title":"Pulmonary arterial hypertension in systemic sclerosis: definition of a screening algorithm for early detection (the ItinerAIR-Sclerodermie Study)","volume":"25","author":"Hachulla","year":"2004","journal-title":"Rev Med Interne"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib46","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.009_bib47","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3899\/jrheum.090997","article-title":"Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis","volume":"37","author":"Cavagna","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib48","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3876","article-title":"N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study","volume":"14","author":"Thakkar","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.009_bib49","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3899\/jrheum.130400","article-title":"Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts","volume":"40","author":"Gladue","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/acr.20693","article-title":"Practical approach to screening for scleroderma-associated pulmonary arterial hypertension","volume":"64","author":"Fischer","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"25 Suppl","key":"10.1016\/j.rdc.2015.04.009_bib51","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.009_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1440-1843.2012.02133.x","article-title":"The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease","volume":"17","author":"Wilsher","year":"2012","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib53","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1164\/rccm.201203-0480OC","article-title":"The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension","volume":"186","author":"Mathai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib54","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1002\/art.22971","article-title":"Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study","volume":"56","author":"Tzelepis","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.009_bib55","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib56","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"Gunther","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib57","first-page":"458","article-title":"Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization","volume":"35","author":"Hsu","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib58","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3899\/jrheum.110512","article-title":"Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension","volume":"38","author":"Mathai","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib59","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/acr.22307","article-title":"Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension","volume":"66","author":"Gopal","year":"2014","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.009_bib60","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/art.30423","article-title":"Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies","volume":"63","author":"Le Pavec","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib62","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ahj.2012.10.020","article-title":"Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: a multicenter study","volume":"165","author":"Gargani","year":"2013","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.009_bib63","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/acr.22051","article-title":"Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis","volume":"65","author":"Bernstein","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.rdc.2015.04.009_bib64","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.2005.069484","article-title":"Systemic sclerosis associated pulmonary hypertension: improved survival in the current era","volume":"92","author":"Williams","year":"2006","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.009_bib65","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/03009742.2010.508751","article-title":"Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult","volume":"40","author":"Hesselstrand","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib67","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib68","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1378\/chest.11-0341","article-title":"Response to \u2018survival in pulmonary hypertension registries: the importance of incident cases\u2019","volume":"139","author":"Chung","year":"2011","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib69","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lefevre","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib70","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1378\/chest.13-3014","article-title":"Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry","volume":"146","author":"Chung","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12016-012-8312-4","article-title":"N-TproBNP as biomarker in systemic sclerosis","volume":"43","author":"Schioppo","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib72","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.rdc.2015.04.009_bib73","doi-asserted-by":"crossref","first-page":"e12106","DOI":"10.1371\/journal.pone.0012106","article-title":"Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury","volume":"5","author":"Pendergrass","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib74","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/rheumatology\/kes068","article-title":"Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis","volume":"51","author":"Barnes","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.009_bib75","first-page":"S632","article-title":"Differential expression of hepatocyte growth factor (HGF) in patients with systemic sclerosis-associated pulmonary arterial hypertension","volume":"64","author":"Chung","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157016111794519381","article-title":"Biomarkers in systemic sclerosis-related pulmonary arterial hypertension","volume":"9","author":"Dimitroulas","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib77","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00296-008-0829-8","article-title":"Potential biomarkers for detecting pulmonary arterial hypertension in patients with systemic sclerosis","volume":"29","author":"Coral-Alvarado","year":"2009","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/ers.09.5","article-title":"Therapies for scleroderma-related pulmonary arterial hypertension","volume":"3","author":"Hassoun","year":"2009","journal-title":"Expert Rev Respir Med"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib79","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1378\/chest.14-0793","article-title":"Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report","volume":"146","author":"Taichman","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib80","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/imj.12111","article-title":"Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?","volume":"43","author":"Nikpour","year":"2013","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib81","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3899\/jrheum.110765","article-title":"Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease","volume":"39","author":"Johnson","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.rdc.2015.04.009_bib83","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3899\/jrheum.081277","article-title":"Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol","volume":"36","author":"Badesch","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib84","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rdc.2015.04.009_bib85","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"issue":"18","key":"10.1016\/j.rdc.2015.04.009_bib86","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.rdc.2015.04.009_bib87","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.11-2212","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and\/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial","volume":"142","author":"Tapson","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib88","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.112.124388","article-title":"Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial","volume":"127","author":"Jing","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.rdc.2015.04.009_bib89","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2015.04.009_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00296-006-0222-4","article-title":"Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary Results","volume":"27","author":"Caramaschi","year":"2006","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib91","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib92","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","article-title":"Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases","volume":"67","author":"Denton","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2015.04.009_bib93","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2015.04.009_bib94","first-page":"82","article-title":"Macitentan and pulmonary arterial hypertension","volume":"370","author":"Macchia","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.rdc.2015.04.009_bib95","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib96","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"Badesch","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"22","key":"10.1016\/j.rdc.2015.04.009_bib97","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.rdc.2015.04.009_bib98","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib99","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1002\/art.22264","article-title":"Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension","volume":"54","author":"Schachna","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2015.04.009_bib100","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.rmed.2013.09.015","article-title":"Survival after lung transplantation in systemic sclerosis. A systematic review","volume":"107","author":"Khan","year":"2013","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.rdc.2015.04.009_bib101","first-page":"S789","article-title":"One-year survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study","volume":"66","author":"Bernstein","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X15000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:14:05Z","timestamp":1760181245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X15000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0889857X15000307"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.009","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2015.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}